July 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJuly 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
Projections indicate that, the global nuclear medicine software market will increase from USD 895.04 million in 2024 to USD 2109.19 million by 2034, experiencing a CAGR of 8.95% over the next 10 years.The global market is fueled by continuous collaborations, initiatives, and advancements in imaging technologies. The major involvement in healthcar...
April 21, 2026
Based on market forecasts, the global healthcare consulting services market, projected at USD 29.15 billion in 2024, is expected to reach USD 75.95 billion by 2034, growing at a CAGR of 10.05% over the forecast period. The healthcare consulting services market is expanding due to growing digital transformation as well as increasing adoption ...
April 21, 2026
According to market projections, the theranostics sector is expected to grow from USD 2.42 billion in 2024 to USD 10.21 billion by 2034, reflecting a CAGR of 15.46%. Technological advancements and boosting non-oncological applications are driving the global market expansion. North America led with its rising cancer cases and healthcare system....
April 21, 2026
Market insights predict, the oxygen concentrators industry is expected to grow from USD 1.21 billion in 2025 to USD 2.18 billion by 2035, driven by a CAGR of 6.06%. The oxygen concentrators market is growing as it is an indispensable piece of equipment for treating respiratory failure, which is used not only in hospitals, but also for home oxygen t...
April 21, 2026
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more reliable detection methods to control outbreaks. Growing awareness, government initiatives, and technol...
April 21, 2026
Market insights predict the global cardiac safety services industry will increase from USD 824.35 million in 2024 to USD 2459.29 million by 2034, achieving a CAGR of 11.55%. The remarkable investments in R&D and significant healthcare reforms contribute to the expansive reach of healthcare systems across the globe. North America dominated the m...
April 21, 2026
According to market projections, the AI in telehealth & telemedicine sector is expected to grow from USD 3.89 billion in 2024 to USD 86.31 billion by 2034, reflecting a CAGR of 36.35%. The AI in telehealth & telemedicine market is growing due to the rising focus on providing home-based healthcare for the geriatric and physically disabled ...
April 21, 2026
Market insights predict the global vendor neutral archive (VNA) & PACS industry will increase from USD 4.66 billion in 2024 to USD 11 billion by 2034, achieving a CAGR of 9.16%. The growing trend of medical imaging technologies to capture, analyze, and diagnose various health conditions raises the demand for digital healthcare technology like...
April 21, 2026
Based on market forecasts, the global electronic clinical outcome assessment (eCOA) solutions market, projected at USD 1.97 billion in 2024, is expected to reach USD 8.77 billion by 2034, growing at a CAGR of 16.04% over the forecast period. The increasing demand for patient-centric approaches and digital health technologies is driving the g...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and clinically equivalent alternatives to biologic cancer treatments. North America is leading the market...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
